These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


187 related items for PubMed ID: 1540410

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Epstein-Barr virus nuclear antigen 2 transactivates the long terminal repeat of human immunodeficiency virus type 1.
    Scala G, Quinto I, Ruocco MR, Mallardo M, Ambrosino C, Squitieri B, Tassone P, Venuta S.
    J Virol; 1993 May; 67(5):2853-61. PubMed ID: 8386279
    [Abstract] [Full Text] [Related]

  • 3. An increase in p50/p65 NF-kB binding to the HIV-1 LTR is not sufficient to increase viral expression in the primary human astrocyte.
    Conant K, Atwood WJ, Traub R, Tornatore C, Major EO.
    Virology; 1994 Dec; 205(2):586-90. PubMed ID: 7975262
    [Abstract] [Full Text] [Related]

  • 4. Different molecular mechanisms of HTLV-1 and HIV LTR activation by TPA.
    Jabareen A, Suleman M, Abu-Jaafar A, Huleihel M.
    Biochem Biophys Res Commun; 2018 Jun 07; 500(3):538-543. PubMed ID: 29660338
    [Abstract] [Full Text] [Related]

  • 5. The long terminal repeats of human immunodeficiency virus type-1 and human T-cell leukemia virus type-I are activated by 12-O-tetradecanoylphorbol-13-acetate through different pathways.
    Mor-Vaknin N, Torgeman A, Galron D, Löchelt M, Flügel RM, Aboud M.
    Virology; 1997 Jun 09; 232(2):337-44. PubMed ID: 9191847
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Activating protein-1 cooperates with phorbol ester activation signals to increase HIV-1 expression.
    Roebuck KA, Gu DS, Kagnoff MF.
    AIDS; 1996 Jul 09; 10(8):819-26. PubMed ID: 8828738
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Synergistic activation of simian immunodeficiency virus and human immunodeficiency virus type 1 transcription by retinoic acid and phorbol ester through an NF-kappa B-independent mechanism.
    Maciaszek JW, Talmage DA, Viglianti GA.
    J Virol; 1994 Oct 09; 68(10):6598-604. PubMed ID: 8083995
    [Abstract] [Full Text] [Related]

  • 12. Drastic decrease of transcription activity due to hypermutated long terminal repeat (LTR) region in different HIV-1 subtypes and recombinants.
    de Arellano ER, Alcamí J, López M, Soriano V, Holguín A.
    Antiviral Res; 2010 Nov 09; 88(2):152-9. PubMed ID: 20713090
    [Abstract] [Full Text] [Related]

  • 13. Second-site long terminal repeat (LTR) revertants of replication-defective human immunodeficiency virus: effects of revertant TATA box motifs on virus infectivity, LTR-directed expression, in vitro RNA synthesis, and binding of basal transcription factors TFIID and TFIIA.
    Kashanchi F, Shibata R, Ross EK, Brady JN, Martin MA.
    J Virol; 1994 May 09; 68(5):3298-307. PubMed ID: 8151790
    [Abstract] [Full Text] [Related]

  • 14. Analysis of the HIV-1 LTR NF-kappaB-proximal Sp site III: evidence for cell type-specific gene regulation and viral replication.
    McAllister JJ, Phillips D, Millhouse S, Conner J, Hogan T, Ross HL, Wigdahl B.
    Virology; 2000 Sep 01; 274(2):262-77. PubMed ID: 10964770
    [Abstract] [Full Text] [Related]

  • 15. Non-mitogenic T cell activation signals are sufficient for induction of human immunodeficiency virus transcription.
    Gruters RA, Otto SA, Al BJ, Verhoeven AJ, Verweij CL, Van Lier RA, Miedema F.
    Eur J Immunol; 1991 Jan 01; 21(1):167-72. PubMed ID: 1846814
    [Abstract] [Full Text] [Related]

  • 16. Phorbol ester reduces constitutive nuclear NF kappa B and inhibits HIV-1 production in mature human monocytic cells.
    Mufson RA, Myers C, Turpin JA, Meltzer M.
    J Leukoc Biol; 1992 Dec 01; 52(6):637-44. PubMed ID: 1464736
    [Abstract] [Full Text] [Related]

  • 17. Cooperative inhibition of NF-kappa B and Tat-induced superactivation of human immunodeficiency virus type 1 long terminal repeat.
    Biswas DK, Ahlers CM, Dezube BJ, Pardee AB.
    Proc Natl Acad Sci U S A; 1993 Dec 01; 90(23):11044-8. PubMed ID: 8248210
    [Abstract] [Full Text] [Related]

  • 18. Human immunodeficiency virus type 1 genome activation induced by human T-cell leukemia virus type 1 Tax protein is through cooperation of NF-kappaB and Tat.
    Cheng H, Tarnok J, Parks WP.
    J Virol; 1998 Aug 01; 72(8):6911-6. PubMed ID: 9658145
    [Abstract] [Full Text] [Related]

  • 19. Human immunodeficiency viruses containing heterologous enhancer/promoters are replication competent and exhibit different lymphocyte tropisms.
    Chang LJ, McNulty E, Martin M.
    J Virol; 1993 Feb 01; 67(2):743-52. PubMed ID: 8419644
    [Abstract] [Full Text] [Related]

  • 20. ERK MAP kinase links cytokine signals to activation of latent HIV-1 infection by stimulating a cooperative interaction of AP-1 and NF-kappaB.
    Yang X, Chen Y, Gabuzda D.
    J Biol Chem; 1999 Sep 24; 274(39):27981-8. PubMed ID: 10488148
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 10.